An Open-Label, Randomized Phase I Study in Healthy Adults of the Safety and Immunogenicity of Prime-Boost Intervals With Monovalent Influenza Subunit Virion (H5N1) Vaccine, A/Indonesia/05/2005 (Sanofi Pasteur, Inc.) Administered Alone or Following Re...
Clinical trial NCT01086657 · COMPLETED
Trial details
- NCT number
- NCT01086657
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-02-25
- Primary completion
- 2011-12-12
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.